MedTrace Logo

Extended Resection After Positive Intraoperative Pathology in Gastric Cancer Surgery

NCT05663450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 679

Last updated 2022-12-23

No results posted yet for this study

Summary

Of 737 consecutive patients undergoing (sub)total gastrectomy for gastric or GEJ adenocarcinoma, 679 cases with curative intent surgery between 05/1996 and 03/2019 were included. Patients were categorized into: i) R0 without further resection (direct R0), ii) R0 after positive IOC and extension of resection (converted R0) and iii) R1.

Conditions

Sponsors & Collaborators

  • University Hospital of Cologne

    lead OTHER

Principal Investigators

  • Hakan Alakus, MD · University Hospital of Cologne

Eligibility

Min Age
59 Years
Max Age
66 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-05-01
Primary Completion
2019-12-31
Completion
2022-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05663450 on ClinicalTrials.gov